Drell; William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Drell; William.The latest application filed is for "use of methylnaltrexone and related compounds to treat constipation in chronic opioid users".

Company Profile

0.6.14

Drell; William - San Diego CA
Drell; William - US
Drell, William - San Diago CA
Drell; William - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Methylnaltrexone And Related Compounds To Treat Constipation In Chronic Opioid Users App 20120277260 - Foss; Joseph F. ; et al.	2012-11-01
Use Of Methylnaltrexone And Related Compounds To Treat Constipation In Chronic Opioid Users App 20120190702 - FOSS; Joseph F. ; et al.	2012-07-26
Use Of Methylnaltrexone And Related Compound To Treat Constipation In Chronic Opioid Users App 20100087472 - Foss; Joseph F. ; et al.	2010-04-08
Use Of Methylnaltrexone And Related Compounds For Treatment Of Gastrointestinal Dysfunction Induced By Endogenous Opioids App 20090312359 - Foss; Joseph F. ; et al.	2009-12-17
Use of methylnaltrexone and related compounds App 20050048117 - Foss, Joseph F. ; et al.	2005-03-03
Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid users App 20040167147 - Foss, Joseph F. ; et al.	2004-08-26
Oral use of methylnaltrexone and related compounds to treat constipation in chronic opioid users App 20040167148 - Foss, Joseph F. ; et al.	2004-08-26
Use of methylnaltrexone and related compounds for treatment of constipation caused by endogenous opioids App 20040162308 - Foss, Joseph F. ; et al.	2004-08-19
Use of methylnal trexone and related compounds to treat constipation in chronic opioid users App 20040162306 - Foss, Joseph F. ; et al.	2004-08-19
Use of methylnaltrexone and related compounds to induce laxation in chronic opioid users App 20040162307 - Foss, Joseph F. ; et al.	2004-08-19
Use of methylnaltrexone and related compounds to treat chronic opioid use side effects App 20030187010 - Foss, Joseph F. ; et al.	2003-10-02
Use of methylnaltrexone and related compounds to treat chronic opioid use side effects App 20030158220 - Foss, Joseph F. ; et al.	2003-08-21
Use of methylnaltrexone and related compounds Grant 6,608,075 - Foss , et al. August 19, 2	2003-08-19
Use of methylnaltrexone and related compounds to treat chronic opioid use side affects Grant 6,559,158 - Foss , et al. May 6, 2	2003-05-06
Use of methylnaltrexone and related compounds App 20030065003 - Foss, Joseph F. ; et al.	2003-04-03
Use of methylnaltrexone and related compounds App 20020028825 - Foss, Joseph F. ; et al.	2002-03-07
Use of methylnaltrexone and related compounds Grant 6,274,591 - Foss , et al. August 14, 2	2001-08-14
Use of methylnaltrexone and related compounds Grant 5,972,954 - Foss , et al. October 26, 1	1999-10-26
Azarbine composition Grant 5,023,083 - Drell June 11, 1	1991-06-11
Process of mitigating cholelithiasis Grant 4,105,794 - Drell , et al. August 8, 1	1978-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.